Trials / Completed
CompletedNCT00791245
Post Market Study of DeNovo NT, Natural Tissue Graft
A Post Market Study of Articular Cartilage Defects of the Knee Treated Wtih DeNovo NT, Natural Tissue Graft
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Zimmer Orthobiologics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human knee joint.
Detailed description
The intent of this post market study is to assess the clinical outcomes of DeNovo NT, a particulated juvenile cartilage tissue for the treatment of one or two contained lesion(s) equal to an ICRS Grade 3a, 3b, 3c, 3d of the femoral condyle or trochlear groove and OCD lesions (Grade 4a) with healed bone base, which is non sclerotic and no loss of bone greater thank 6mm measured from the surrounding subchondral plate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Particulated Juvenile Cartilage Allograft | Particulated Juvenile Cartilage Allograft |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2008-11-14
- Last updated
- 2014-08-11
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00791245. Inclusion in this directory is not an endorsement.